Here we report on the use of spectral map analysis of time-paired sequential neutralization data of 11 serum samples of a chimpanzee naturally infected with a simian immunodeficiency virus (STVcpz-ant) and 8 primary consecutive SIVcpz-ant isolates, taken at about 4-month intervals. The analysis reveals the existence of three SNcpz-ant isolate and serum neutralization clusters. Each cluster groups virus isolates and/or sera based on similarities of their neutralization spectra. On average, neutralization escape mutants emerged after 15 months and mounted a neutralization response approximately 8 months later. The entire gp160 regions of eight consecutive isolates were sequenced and analyzed by a new statistical method called polygram, which allowed the deduction of amino acid sequence motifs of gp160 which were specific for SIVcpz-ant isolates belonging to the same isolate neutralization clusters. Changes in specific'amino acid quadruplets in V1, V2, C3,V4, V5, and CD4 domains of gp120 and gp40 were seen to correlate with the neutralization clusters with most of the specific changes occuring in the V4 region. This method of analysis may facilitate an understanding of the study of the dynamic interplay between human immunodeficiency virus (HIV) and host neutralization responses as well as providing possible insights into mechanisms of persistence of HN-1-refated lentiviruses in their natural hosts.
The simian immunodeficiency virus (SIVcpz), isolated from wild-captured, naturally infected chimpanzees, is the most closely related isolate of nonhuman origin to the human immunodeficiency virus (HIV) type 1 (20, 44, 53) and thus provides an opportunity to study the interactions between primate lentiviruses and their host. Isolates of HIV, even those taken from the same individual at different times postinfection, are genetically and biologically variable (12, 33, 42, 57, 58) . In particular, individual variants of HIV differ in phenotype, and the appearance of more virulent strains within a patient has been associated with the development of AIDS (4, 7, 13, 48, 52) . In HIV-1-infected persons, neutralization depends on the association of antibodies with various linear epitopes, such as those of the V3 loop, but importantly with other discontinuous and conformational epitopes of the HIV-1 envelope glycoproteins (11, 17, lS, 34, 35, 51) . The SIVcpz-ant isolate was isolated from a naturally infected chimpanzee which was impounded by customs officers in Brussels upon illegal arrival in Belgium from Zaire (44) and, based on sequence information, is closely related to HIV-1 (53) . How sequence variation in SIVcpz-ant envelope glycoproteins might affect the occurrence of neutralization escape mutants is not yet well documented. Insights into this question may provide a better understanding of the mechanism of HIV persistence.
HIV persistence is a complex kinetic phenomenon of simultaneous interaction of virus, cells, and humoral and cellular immune responses. According to Nowak and May (37) , HIV persistence may be explained in terms of escape mutants 33. emerging faster than the immune system can induce highquality neutralizing antibodies. Despite the development of virus variants with reduced sensitivity to neutralization by timepaired sequential sera as observed in our previous study (45) , a remarkably consistent nucleic acid sequence of the V3 region was observed in the consecutive SIVcpz-ant isolates (45) . This suggested that escape from the humoral immune response could be due to changes in the envelope gene other than in the V3 loop. In the context of developing 3 protective vaccine capable of inducing neutralizing antibodies, the causal relationship between escape from neutralization and the eventual outgrowth of virus variants needs to be demonstrated. Furthermore, little is known about the time required to generate sufficient genetic diversity in the envelope protein of SIV isolates for neutralization escape mutants to emerge, as well as the time required to mount an adequate neutralization response against newly appearing virus variants in a naturally infected chimpanzee.
Recently, we applied spectral map analysis, a multivariate statistical method of data analysis (25) (26) (27) (28) (29) , to study the interand intraclade cross-neutralization of primary HIV-1 isolates by their homologous and heterologous polyclonal sera from individuals infected with different genetic subtypes of HIV-1 groups M and O (40) . In the present study, we apply this analysis to determine the kinetics of the appearance of SIVcpZant neutralization escape mutants and correlate neutralization escape with amino acid mutation patterns in the gp160 of sequential SIVcpz-ant strains. Sera and isolates were tested in a time-paired sequential manner in neutralization assays with human peripheral blood mononuclear cells (PBMCs) as target cells. .The gp160 env sequences of the isolates were determined. The term "time-paired sequential" means that sera and isolates were collected from the same sample taken during a consecutive bleeding schedule from a particular individual. At intervals of about 15 months, neutralization escape mutants evolved, and these eventually formed three clusters. Approximal ~l y 8 months later, neutralizing antibodies were detected against the escape mutants. Furthermore, polygram analysis (8) revealed that changes in the V1, V2, C3, V4, V5, CD4, and gp40 domains of the envelope in the sequential isolates correlated with the neutralization escape mutants in each cluster.
MATERIALS AND METHODS
nter in Rijswijk, The Netherlands. This animal ay. The neutralizing capacity of the sequential sera to the as tested in a time-paired sequential manner in a classical vith human PBMCs as target cells as previously described were defined as the highest serum dilutions that produced 290% redu ort (40) , and only the main steps are briefly discussed here. MC, = -zyi,, the jth column mean of y n .
'I
"P i i mg=-2 x y i j , the global mean of y Double-centering corrects for differences in average neutralization activity of the sera and of the isolates. As a result, thc row, column, and global means of the doubly centered dots are all equal to zero.
(iii) Step 3. Extraction of eigenvectors (u and v), also called principal coniponents or factors, from the table of neutralization specificities (2) is given as P u;p = 2 zijvjp A; ' with k = 1, . . . , r
where r is the number of eigenvectors that have been extracted. The coefficients A are the square roots of the associated eigenvalues, which can be interpreted as the variances in the table of neutralization specificities (2) accounted for by the corresponding eigenvectors (u and v). Furthermore, eigenvectors (u and v) are required to be orthonormal, which can be expressed by means of the conditions i where Skk = 1 if k = k' and 6 , = O otherwise. The eigenvectors (u and v) are the principal components or factors of the neutralization specificities (2) and are, by convention, arranged in decreasing order of their contributions (A' ) to the global variance of specificities. The calculations can be performed by means of standard programs for eigenvector extraction, which are available in most scientific programming libraries.
(iv)
Step 4. Scaling of eigenvectors (u and v) into coordinates of the sera (s) and the isolates (I) in factor space is given as sik = uil i ; / * , factor coordinates or scores of sera
factor coordinates or loadings of isolates Factor scores and factor loadings are compiled into a factor table, which provides the corresponding coordinates in factor space for each serum and each isolate. The horizontal and vertical axes of a factor plot of the sera and of the isolates usually represent the first hvo most important factors. A third factor can be represented on such a plot by varying the thickness of the contours of the symbols (circles for sera and squares for isolates, by convention). gp160 sequence analysis. For 10 SIVcpz-ant strains, the provirus DNA gp160 sequence was determined. In addition, the V3 sequences of the sequential isolates in viral RNA of plasma were determined. RNA was extracted from 100 y1 of plasma (5) and reverse transcribed (9, 54) . A 277-bp fragment encompassing the V3 loop was amplified and sequenced as described previously (45) .
T o determine the gp160 sequence from the proviral DNA, virus was isolated by cocultivation of PBMCs from the chimpanzee with phytohemagglutinin-stimulated lymphocytes from healthy (HIV-negative) human donors, as described previously (45) . Primers for PCR of the envelope gene were designed by using sequence information of the first sequenced isolate (Nhl) (53) . A nested PCR was carried out in a 100-y1 reaction mixture containing 50 mM KCI, 10 mM Tris-HC1 (pH 83), 2.5 mM MgCl,, 0.01% gelatin, 0.2 mM each deoxynucleoside triphosphate, 0.4 pM each primer, and 2.5 U of Taq DNA polymerase (PerkinElmer Cetus Corp., Zaventem, Belgium). An aliquot corresponding to 1 yg of DNA was subjected to a first PCR round of 35 cycles with the outer primers 93C285 (5' CCTCCATGGTTACACCCTCCTGC 3') and SIV3968 (5' GGAA CITGAGGTCTCACAGGAAAGCC 3'). Cycle conditions were 1 min each at 94 and 50°C and 5 min ac 72°C. with an extension of 7 min at 72°C in a termal DNA cycler machine (Perkin-Elmer Cetus Corp.). Amplified DNA (Spi) was subjected to a second round of 25 cycles with conditions as noted above with inner primers SCE1601 (5' ggtctagAATAGAAGAAGATGATGAGGAAGCCG 3') and SIVE3776 (5' ccctcgagATI'TTAGACCATGCAGAACCCAT 3'). Restriction sites (indicated in lowercase type) were added to the 5' end of the primers for cloning purposes.
For three isolates (Nh3, Nh8, and Nh9), the total envelope gene was amplified successfully. Because of failure to amplify the remaining isolates with the nested primer combination described above, PCR fragments were obtained for the gp120-and part of the gp41-encoding envelope region and for the gp41-encoding envelope region, seperately (isolates Nh2, Nh4, Nh5, Nh6, Nh7, and NhlO). For the envelope fragments encoding gp120 and part of gp41, the outer primers were 93C285 and'93C284 (5' GGTGCTGAGA?TGTTCTCCAGATGG 3') and the inner primers were SCE1601 and SCE1602 (5' ggaagcttGGTGlTGGAGGAC TGCCC 3'). For the envelope fragments encoding envelope gp41, the outer primers were SIV3384 (5' TCATITCAGATCCCTACCCAAAACCAG 3') and 22, 25, 29, 33 , and 41 months were tested for neutralizing antibodies against the corresponding SIVcpz-ant isolates obtained at the same moment. The corresponding isolates at 3 months (1, 38, and 41) were not included in the analysis.
SIV3968 and the inner primers were BSIV3456 (biotin-5' AAAGACÅGGATC AGGTGGAGGG 3') and SIV3776. Cycle conditions were 1 min each at 94,50, and 72T, with an extension of 5 min at 72°C. Amplification products were cloned and sequenced on a A.L.F. automatic sequencer (Pharmacia Biotech), except for the gp41 amplification products, for which direct sequencing was done.
Polygram analysis. The entire gp160 sequences of 10 serial SIVcpz-ant strains were scanned for the presence of specific quadruplets formed by four adjacent amino acids as previously described (8). A quadruplet is considered specific for a given sequence if it occurs in that sequence and only rarely or not at all in all other sequences.
The measure of specificity of a given quadruplet i for a sequence of the particular type k is given by means of a chi-square statistic (x'):
where N is the total number of sequences in the set that is studied, a is the number of sequences of type k in which quadruplet i occurs, b is the number of sequences of type k in which quadruplet i does not occur, c is the number of sequences not of type k in which quadruplet i occurs, and d is the number of sequences not of type k in which quadruplet i does nqt occur. Quadruplets of amino acids are preferred because they were previously found to be the most sensitive in representing specific amino acid changes in the test sequence (8). To visualize the pattern of specific quadruplets, we represented each SIVcpz-ant gp160 sequence by a horizontal line segment. If the specificity of a particular amino acid quadruplet is significant, a vertical mark was placed along the line at the position where the quadruplet occurred in the test sequence. This process was repeated for each of the 10 serial gp160 SIVcpz-ant sequences. Finally, we obtained a set of 10 parallel tracings, which is called a polygram, because it resembles the tracings produced by a polygraph recorder. Similarities among the 10 serial gp160 SIVcpz-ant sequences, in terms of specific amino acid quadruplet distribution, can be identified visually or by counting the number of significant quadruplets for each gp160 swcpz-ant sequence studied.
This method was extended to SIVcpz-ant gp160 sequences of isolates which belong to the same SIVcpz-ant isolate neutralization cluster. In this extended case, an amino acid quadruplet is specific for a given isolate neutralization cluster, if it occurs in most of the members Of that neutralization cluster and rarely or not at all in the members of other isolate neutralization clusters. This extended polygram approach allowed us to identify amino acid quadruplet patterns that are specific to the previously determined isolate neutralization clusters.
Nucleotide sequence accession numbers. The nucleotide sequence data were deposited in the EMBL, GenBank, and DDBJ nucleotide sequence databases.
RESULTS
Serial Sflcpz-ant isolate-serum neutralization spectra. The serial SIVcpz-ant isolate-serum neutralization data depicted in Table 1 has been published previously (45) and is presented here for this analysis. The first 11 rows and first 8 columns represent the serum and isolate neutralization spectra, respectively, with progression of time. The (geometrical) mean neutralization titers observed from each serum sample are listed in the right-hand column of the table. These values provide a measure of the neutralizing potency of the corresponding sera. Note the increasing progression of the neutralizing potency of the sera between months O and 41. Initially, at month O, the serum did not possess any neutralizing capacity. As time progressed, the serum became increasingly more capable of neutralizing isolates. The (geometrical) mean neutralization titers of each isolate are shown in the bottom row of the table. These constitute a measure of the sensitivity for neutralization of the corresponding isolates. We observe that the sensitivity to neutralization of the isolates varied over time.
Two spectra are considered to be similar if they agreed according to their shape, i.e., independently of the potency of the serum or the sensitivity of the isolate. For example, the spectra of isolates at months 7 and 15 are rather similar if one makes allowance for their difference in sensitivity. On the other hand, the spectra of isolates at 15 and 29 months are different. The same reasoning can be applied to the spectra of the sera at 33 and 41 months, which are similar, and to those at months 15 and 41 which are very different.
Spectral map analysis of time-paired sequential sera and isolates. The neutralization data (ID9,,) in Table 1 were subjected to spectral map analysis. The logarithmic titers were double-centered, and a table of specificities (Table 2) was obtained. Double-centering consisted of subtracting simultaneously the corresponding row and column means from each element of the table. It is seen as a correction of the titers for differences in potency of the sera and for differences in sensitivity of the isolates. Note that specificities are relative values which add to zero both row-and columnwise. The table of specificities indicates the specificity (positive or negative) of the interactions between sera and isolates. Positive specificity Table 3 .) For reasons that will be pointed out below, we attach no relevance here to the third-and higher-order factors. By convention of the spectral map, we represent isolates by means of squares and sera by means of circles. The areas of the squares and circles indicate the sensitivity and potency of the corresponding isolates and sera, respectively. In this case, the areas of the symbols were made proportional to the corresponding (geometrical) mean neutralization titers (Table 1) .
If the spectra of two isolates are similar (in shape, irrespective of a dif€erence in sensitivity), their positions will also be close on the spectral map (this applies to the isolates at months 7 and 15) (Fig. 1 ). If they are dissimilar (as is the case with isolates at months 15 and 29), they will appear to be separated. Likewise if the spectra of two sera are similar (in shape, irrespective of a difference in potency), the sera will be found close together on the spectral map (this is the case for sera at months 33 and 41) (Fig. 2 ). Spectra that are dissimilar (such as the sera at months 15 and 41) will be found at a distance from one Table 2 . As explained in the text, these two factors account for the structural information in the data, i.e., the information that is not caused by measurement errors and artifacts. They account for 61 and 20% of the variance, respectively. Other conventions are as described in the legend to Fig. 1 Table 1 . The horizontal and vertical axes of the diagram represent the two structural factors of the specificities between sera and isolates in Table 2 . They account for 61 and 20% of the variance, respectively. A third nonsystematic factor, accounting for 13% of the variance, is encoded in the variable thickness of the contours of the circles. The coordinate axes are not shown explicitly. The small cross at the center defines the origin of the coordinate axes. The labels indicate the month at which the serum was taken. An arc has been added to indicate the progression of time. The grouping of the sera is according to their specificity for the clusters of isolates determined by the U P G M method (Fig.  1) . Note that the semm at 15 months is shared by hvo groups, as it shows mixed specificity for the cluster defined by the isolate at O months and by the cluster which comprises ísolates at 7 to 22 months. The grouping of the isolates on this figure has been determined from inspection of Table 2 , and the result is shown in Fig. 3 . t, origin of the coordinate axes.
one-out method and by predicting their values by means of spectral map analysis, as described above, using only the data that remain. The process was repeated until predictions for all elements in the data table were obtained. When this was completed, the error between the observed and predicted values was plotted against the number of factors that were extracted (which ranges from 1 to 7 in this case). The error statistic is called PRESS (prediction error sum of squares) (1, 40) . Initially, the error decreases because the first factors usually account for a large part of the structural variance in the data. The higher-order factors, however, add to the epor, since they contain mostly noise. Hence, a plot of PReSS against the number of factors usually shows a minimum (plot not shown). The factor which produces minimal PRESS contains about equal parts of structura1 information and noise. Hence, structural factors are those that precede (in terms of contribution to the variance) the factor with minimal PRESS. In this case, we found that only the first two factors (accounting together for 81% of the variance) carry structural information. Hence, the third-and higher-order factors (which account together for 19% of the variance) are due to noise and nonsystematic variation in the data. The latter is caused by experimental error and some anomalies in the neutralization data mentioned above.
Isolate and serum neutralization cluster analysis. To understand the temporal relationships between isolates and sera, we first performed a hierarchiral (agglomerative) Cluster analysis on the isolates to determine which of these can be grouped together. Cluster analysis by the unweighted pair-group mean J. VIROL. arithmetic method (UPGMA) was applied, using only the two structural factors that were identified above (50) . TO this effect, only the first two columns of the factor table for isolates (Table  3) were submitted to cluster analysis. This effectively eliminated the noise and the nonsystematic variation in the data. The UPGMA analysis yielded three clusters (at 61% of the maximal agglomeration distance). These three clusters are composed of the isolate at O months, the isolates between 7 and 22 months, and the isolates between 25 and 33 months, respectively, as distinguished by contours on Fig. 1 . Next, we defined the sera that are positively specific for these three clusters of isolates. For this purpose, we computed the mean specificities for the three clusters of isolates from the data in Table 2 . The result is displayed in Fig. 3 , which shows the mean specificity obtained at different times of serum collection (ranging from O to 41 months) for each of the three clusters of isolates. We observed three rather disjoined periods. The first period extended between 1 and 15 months, during which the sera showed positive specificity for isolate O and negative specificity for all other isolates. The second period ranged from 15 to 29 months, during which the sera possessed positive specificity for isolates taken between 7 and 22 months. Finally, the third period started at 33 months until thè end of the observation period at 41 months, during which the serum showed positive specificity for isolates at months 25 to 33. Note that there is an overlap between the first two groups of sera at month 15. As can be seen from Table 2 , the serum at month 15 is positively specific for all isolates between months O and 22.
The spectral maps for isolates and sera ( Fig. 1 and 2 ) can also be superimposed, such that the origin (small cross at the center) and coordinate axes coincide. This produces a joint spectral map which represents both sera and isolates on the same diagram and provides a graphic interpretation of the interactions between sera and isolates. The origin of the map represents the point of zero specificity. Sera and isolates that are at a distance from the center and that point in the same direction possess positive specificity; similarly, sera and isolates in opposite directions indicate negative specificity. The group of sera at 1 to 15 months and the isolate at O months are (37) --a The correlation was derived from the results of spectrai map analysis (Fig. 3) . Inten& refer to the months after the start of the experiment during which the isolates and XXI where ohlained. Values in parentheses represent the midpoints bf the intervals.
positioned at a distance from the center and in the same @ection. Hence, they possess a specific neutralizing interaction. Likewise, the group of sera at 18 to 29 months is positively ipecific for the cluster of isolates at 7 to 22 months. Finally, iositive specificity is displayed between the group of sera at 33 $41 months and the cluster of isolates at 25 to 33 months. ,These observations are in agreement with the results of cluster ,$alysis, which were discussed above. f The temporal relationships between sera and isolates are summarized in Table 4 . If we consider the midpoints of the clusters of isolates (0, 14.5, and 29 months), we find that they are separated by about X-month intervals. If we look at the $aidpoints of the groups of sera (8,22, and 37 months), we also find Ihat they are separated by intervals of about 15 months. Furthermore, the differences in time between the midpoints of the clusters of isolates and the groups of sera that are positively specific for them amount to about S months. Our analysis of the data from this sequential neutralization experiment on a single individual suggests that major changes in the antigenic 'tleterminants of the isolates occurred at about 15-month intervals. It also suggests that effective neutralization may have taken up to 8 months to develop after appearance of a new intigenic determinant. To obtain a rough check on the last state:!lent, we looked at the difference between the time at Which each isolate was taken and the time that neutralization titers of at least 80 first appeared in the serum. The average difference amounts to 8.2 months (Table 5) , which confirms the finding from the combined spectral map and cluster analysis. I Sequence analysis. Iii our previous study, we have shown that the nucleic acid sequence of the V3 region was remarkably itable over time for sequential isolates (45) . These results iaggest that regions other than the V3 loop may play a role in the emergence of neutralization-resistant viruses. Therefore, ihe ei::ire gp160 regions of the sequential SIVcpz-ant isolates pjere sequenced. It is clear that the gp160 regions of all se-,,@ntial isolates differ from each other. In addition, wgapplied ?-laster analysis by the UPGMA method to the 10 aligned sequences (data not shown). The clusters we identified from I&e sequence data did not agree, however, with the clusters :th t a resulted from the neutralization data. We found three Sequence clusters (at 74% of the maximal agglomeration dist8nce) composed of isolates at months 0 to 15, months 1s to 29 ?nd months 33 to 38. This indicates that neutralization, if it ii Ldirected to antigenic determinants of gp160, is directed to !siecifiu sites of this protein. The problem, then, was to localize +@ons within the protein sequence where specific changes ;dccurred according to the pattern determined by the three @tralization clusters. In other words, we wanted to identify $etions where an amino acid motif is present in sequences at ,&nths 0 and 1 and absent in all the others and where another Motif is present in sequences at months 7 ;o 22 and absent in @others, and where, finally, yet another motif is present in ,!I< sequences at months 25 to 38 and absent in all others. For this purpose, a statistical method of sequence identification and elucidation, the polygram method, was applied to attempt to explain why certain sequential isolates escape neutralization. The three neutralization clusters of gp160 sequences were group 1, comprising two sequences (at 0 and 1 month); group 2, composed of four sequences (between 7 and 22 months); and group 3, containing four sequences (between 25 and 38 months). Each of the 10 individual sequences was tested for quadruplets that are specific for each of the three groups of sequences. The result of the analysis is represented in Fig. 4 . In  Fig. 4a , each of the 10 sequences is tested for specific quadruplets in group 1 (0 and 1 month). In Fig. 4b , the same 10 sequences are tested for specific quadruplets in group 2 (7 to 22 months), and Fig. 4c shows the same again in group 3 (25 to 38 months). In Fig. 4a , we observe that sequences at 0 and 1 month possess highly specific quadruplets for the group 1 isolates in the Vl, V2, V4, V5, CD4, and gp40 regions. Figure 4b shows that sequences at months 7 to 22 possess highly specific quadruplets for group 2 isolates in the V4 region. Finally, Fig.  4c reveals that sequences at months 25 to 38 have highly specific quadruplets for group 3 isolates in the Yl, V4, and gp40 regions. An extensive overlap of the specific changes in the C3 region is observed. These results suggest that the Vl, V2, C3, V4, V5, CD4 and gp40 regions of gp160 may be involved as specific antigenic determinants in the neutralization process. Figure 5 also shows the amino acid sequences of the variable regions in the sequential SIVcpz-ant isolates. However, the entire gp160 of the sequential isolates will be described (unpublished data). The evidence in favor of this hypothesis is that the patterns of amino acid mutations in these regions coincide with the clusters of isolates determined from the neutralization assays. It is perhaps noteworthy that V4 is the only region where specific changes have occurred at the same location of the sequences in each of the three clusters of isolates.
The V3 loop sequence of SIVcpz-ant in PBMC of the sequential isolates was remarkably stable (45) . To verify whether the viruses present in the PBMC and plasma were similar, we sequenced the V3 loop region of the virus present in plasma as well. We observed that the V3 loop of the virus present in plasma remained unchanged and similar to that in the PBMC (data not shown).
DISCUSSION
The close relationship of SIVcpz-ant to HIV-l may help to improve our understanding of the interaction between the host and the virus in HIV-l-infected individuals. The clinical relevance of neutralizing antibodies in HIV persistence remains uncertain, and their effect in controlling viral spread is not clear. ups of isolates were determincd from the spectral map and cluster analysis of the sequentin1 neutralization data (Fig. 1) . Each horizontal tracing represents 1 of 10 nsecutive isolates which were colkctcd betwcen O and 35 months. Vertical marks indicate the Occurrence of a quadruplet, at the corresponding position in the which is spccific for il particular group of isolates. The numbers in the right margin provide the count of specific quadruplets for the particular group of isolates occurled in each of the 10 secJuenccs. The points at which highly specific quadruplets occur for each of the three clusters of isolates are indicated on the panels of arrows at the bottom of thc polygrams. The threshold of significance for quadruplets was fixed at 1.5. this study, spectral map analysis of the neutralization data cted in Table 1 allowed US to group both isolates and sera a number of neutralization spectrum clusters. Each cluster those isolates or sera with sufficient similarity in the of their neutralization spectra ( Fig. 1 and 2) . Cluster s by UPGMA indicated that neutralization escape mumerged on average at about 15-month intervals. The rences between the midpoints of the isolate neutralization trum clusters and the serum neutralization spectrum cluswhich are positively specific for each other amounts to 8 months, suggesting that on average, 8 months is reto mount an adequate neutralization response against a lization escape mutant. observations of the naturally infected chimpanzee seem late with the predictions as formulated by Bremer-) about the mechanism of HIV persistence in humans, escape mutants can emerge and will gradually take over, D : as the avidity of neutralizing antibodies directed against cific mutant is lower than that of antibodies against comg strains. Bremermann predicted that the takeover by an escape mutant would require months, which fits with our observations in the naturally infected chimpanzee.
HIV persistence by escape of mutants which emerge faster than the immune system can respond may eventually generate high-quality antibody responses (37) . The chimpanzee we have studied is estimated to be approximately 9 years old at the time of writing. During the last 5 years of follow-up, the animal has remained clinically asymptomatic. Virus could frequently be isolated from PBMC and from plasma, while the CD4+ cell counts remained relatively stable (45) .
From this study, we hypothesize that the role of neutralizing antibodies in the clinical evolution of the infection in this naturally infected chimpanzee is determined by at least three factors. These include the speed at which SIVcpz-ant diversity takes place, by the speed at which neutralization escape mutants are generated, and the speed at which an appropriate neutralization response is induced against the escape mutants. However, in HIV-1-infected humans, at least four serial different virus neutralization patterns can be hypothesized, including (i) patients in whom the generation of neutralïzation escape mutants is slow and the time required to mount an adequate ncutralization response is slow: (ii) patients in whom the gencration of neutralization escape rnutanls is fast and the time required to mount an adequate neutralization response is long; (iii) patients in whom the generation of ncutralization escape mutants is slow and the time required to niount an adequate neutralization response is short; and (iv) patients in whoni the generation of iieutralization escape mutants is fast and the time required to mount an adequate neutralization response is short. The results of our analysis of the neutralization escape pattern in the naturally infected chimpanzee seem to correlate with the last two hypotheses. These suggest that this lentivirus in this host niay be behaving as an HIV-1-infected human long-term nonprogressor, The 15-month period taken for evolution of a neutralization escape mutant and the S month taken to mount an appropriate neutralizing response could be compatible with the clinical status of a long-term nonprogressor.
Evidence exists that the immune response to HIV-1 results in the continuous selection of new viral variants (3. 10. 19, 32. 49, 55) . A dynamic immune response should result in positive selective pressure on viral epitopes. resulting in a succession of epitopic variants. We believe that the data presented in this study support this hypothesis. Thus. if this same approach were applied to HIV-infected indi\,iduals. differences between rapid progressors and long-term nonprogressors based on the time required for neutralization escape mutant formation and for mounting an appropriate neutralizing antibody response might be quantified. In this contest. studies are under \yay to compare the sequential neutralization pattern of the naturally lentivirus-infected chimpanzee \vi.ith the patterns of HIV-I -infected individuals belonging to the rapid. intermittent. and long-term nonprogressor categories. The sanie study approach may also allow us to verify if a s\vitch in sequential virus neutralization can help to predict disease progression in longterm asymptomatic patients. Honwer. it must be emphasized that the persistence of HIV is a complex niultifactorial interaction of the virus and the host humoral and cellular immune response (6) . Nowak et al. (38) have developed a model based on the observed antigenic variation \vitJiin CTL n.hich may be responsible for viral persistence. However. the contribution of antigenic variation in neutralization and CTL epitopes to HIV viral persistence is still unclear.
The second objective of this report was to better understand the SIVcpz-ant neutralization escape with changes in the gpl60 of SIVcpz-ant strains isolated at different moments of the infection. The lack of correlation benveen the phylogenetic clusters calculated by UPGMX and the isolate neutralization spectra clusters indicated that neutralization is directed to specific antigenic determinants in gp160 and not to gplG0 3s a whole. Interestingly, polygram analpis demonstrated that particular amino acid quadruplets in the hypeivariabk regiuns V1. V2, C3, V4, V5. and CD4. as well as gp40 regions. are involved as specific determinants in thc ncutralization process. This is supported by the pattern of anlino acid mutations in these regions coinciding with the isolate neutralization clustzrs defined by the spectral map analysis.
Several rcports have shown the V3 loop of HIV-I to be the principal neutralization domain (15, 50, 33, 41. 471, and this region has been shown to be involved in neutralization escape in sequential isolates obtained from persons naturally infected with HIV-1 (33) . It was striking that the V3 loop sequences of the sequential SIVcpz-ant in PBMC a n d in plasina were stable. However, this obscrvation docs not cxcludc the role of tlic V3 loop in neutralization, becousc it is possiblc that amino acid J. VIRO^. changes in other rêgions \ d l change the microconfor~iiation of the V3 loop for the virus to escape neutralizalion.
It is remarkable that specific amino acid quadruplets in the V4 region correlate with the changes of the neutralization patterns of the isolates (Fig. 4 ). Our findings demonstrate the importance of highly specific amino acid quadruplets in the V4 region, which might have affected neutralization escape. These amino acid quadruplets in V4 perhaps contribute to a significant change in the overall conformation of the envelope protein of SIVcpz-ant, as previously reported in HIV-infected individuals (23, 46, 56) . In these studies, it was denionstratcd that V4 and V5 deletion mutations in gp120 affected the capacity to bind to CD4, as well as deletions and insertions in V4 which may have contributed to destabilization of the gp120 molecule. Perhaps the specific amino acid quadruplet changes in the V4 region contribute significantly to the generation of neutralization escape mutants. If so, they may be considered one of the two most important factors which rule the spectral map analysis of the neutralization data in Table 1 .
The suggestion that broadening of the immune response to a particular region results in an increased rate of sequence evolution for that region implies that regions of HIV-1 envelope may evolve at differential rates. There is experimental evidence for differential rates of evolution between hypervariable regions from longitudinal studies of envelope sequence variation (21: 23: 43). In our study. based. on the polygram analysis, the largest number of amino acid quadruplets specific for a particular isolate neutralization cluster was situated in the V4 region (seven quadruplets) followed by V1 (three). gp40 (three), V2 (one). CI! (one). and the region between CDI (one) and V5 (one). These data support the notion rhat differential rates of evolution within the SIVcpz-ant envelope gene could reflect differential rates of selective forces on envelope epitopes. Furthermore. we believe that amino acid quadruplet changes in V4 contribute IO perhaps the most important factor which rules the spectral map analysis data. 111 addition, the V1 and gp40 of SlVcpz-ant may contribute to the second factor which rules the spectral map analysis of the serial neutralization data, thus indicating the second most important factor in inducing neutralization escape SIVcpz-ant mutants. These observations corroborate the observations of others in HIV-infected individuals whereby the external portion of gpdl in HIV-1 is involved in antibody neutralization (35) . Se\:erd studies have demonstrated that the hypervariable domains in VI or V? and in V4 or V5 of gpl20 in HIV-1 could induce neutralizing antibodies (13, 16. 31. 36, 40, 56) . These obsen'atioiis suggest that this lentivirus infection with its patterns of neutralization escape is analogous to the HIV-1 neutralization escape phenomenon observcd in many infected humans.
In conclusion, the spectral map analysis of sequential neutralization data in a chimpanzee naturally infected with SIVcpz-ant demonstrated that an average of about 15 months is required to generate neutralization escape mutants and :ln average of about S months is required to mount an adetlLi:lte neutralizing antibody response. Furthermore. the polggr:lm analysis of specific amino acid quadruplets in the gplf~u Of serial sequences of SIVcpz-ant revealed that the changes which occurred in the Vl, V3, C3, V4, Vj, 0 4 , and gp40 regions correspond to the pattern of isolate neutralization clusters. Multivariate analysis of serial neutralization data of HIV-infected patients with different clinical progression are under way to monitor the dynamics of neutralization escape in infected humans and to compare these patterns with the observations we have made with this naturally lentivirus-infected chimpanzee.
